Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening With or Without Different Spacer Types in Patients With Asthma
Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening With or Without Different Spacer Types in Patients With Asthma
The aim of the present study is to investigate the efficacy and safety of ciclesonide on lung function and safety. Ciclesonide will be inhaled at one dose level once daily, using an inhaler device with or without spacer. The study duration consists of a baseline period (1 to 3 weeks) and a treatment period (12 weeks).
Main Inclusion Criteria:
Main Exclusion Criteria:
La Malbaie, Quebec, G5A 1W7, Canada
Montreal, Quebec, H1V 1X5, Canada
Sainte-Foy, Quebec, G1V4G5, Canada
Winnipeg MB, R3C 0N2, Canada
Ferolles-Attily, 77150, France
Budapet, 1529, Hungary
Nyiregyháza, 4412, Hungary
Mumbai, Dadar (E), 400 014, India